​

vTv Therapeutics Ownership | Who Owns vTv Therapeutics?

OverviewForecastRevenueFinancialsChart

vTv Therapeutics Ownership Summary

vTv Therapeutics is owned by 8.91% institutional investors, 35.60% insiders, and 55.49% retail investors. Samsara biocapital is the largest institutional shareholder, holding 3.14% of VTVT shares. Fidelity Select Biotechnology is the top mutual fund, with 6.81% of its assets in vTv Therapeutics shares.

VTVT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockvTv Therapeutics8.91%35.60%55.49%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Samsara biocapital206.78K3.14%$3.10M
Baker bros. advisors lp97.31K1.48%$1.46M
Connective capital management9.71K0.15%$145.68K
Blackrock funding, inc. /de4.83K0.07%$72.41K
Activest wealth management50.000.00%$750.00
Sunbelt securities15.000.00%$207.00
Jpmorgan chase---
Strategic wealth partners1.00-$15.00
Tower research capital llc (trc)---
Raymond james financial1.00-$15.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Samsara biocapital206.78K0.63%$3.10M
Connective capital management9.71K0.14%$145.68K
Baker bros. advisors lp97.31K0.01%$1.46M
Activest wealth management50.000.00%$750.00
Sunbelt securities15.00-$207.00
Strategic wealth partners1.00-$15.00
Jpmorgan chase---
Tower research capital llc (trc)---
Blackrock funding, inc. /de4.83K-$72.41K
Raymond james financial1.00-$15.00

Top Buyers

HolderShares% AssetsChange
Connective capital management9.71K0.14%335.00
Blackrock funding, inc. /de4.83K-123.00
Raymond james financial1.00-1.00
Strategic wealth partners1.00-1.00
Sunbelt securities15.00--

Top Sellers

HolderShares% AssetsChange
Tower research capital llc (trc)---394.00
Jpmorgan chase---3.00
Baker bros. advisors lp97.31K0.01%-
Samsara biocapital206.78K0.63%-
Sunbelt securities15.00--

New Positions

HolderShares% AssetsChangeValue
Raymond james financial1.00-1.00$15.00
Strategic wealth partners1.00-1.00$15.00

Sold Out

HolderChange
Jpmorgan chase-3.00
Tower research capital llc (trc)-394.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025215.00%587,1232.70%811.82%814.29%4-20.00%
Mar 31, 20252017.65%571,7123.68%89.51%716.67%5-
Dec 31, 202417-15.00%551,4241.68%99.67%6-25.00%--100.00%
Sep 30, 2024205.26%542,32455.78%933.63%8-1-
Jun 30, 202419-348,1404.34%58.38%8-27.27%1-75.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology178.20K6.81%-
Vanguard US Total Market Shares ETF33.45K1.28%-211.00
Vanguard Total Stock Mkt Idx Inv32.95K1.26%-720.00
Vanguard Institutional Extnd Mkt Idx Tr7.03K0.27%-2.24K
Fidelity Extended Market Index5.62K0.21%-15.00
Northern Small Cap Core I4.45K0.17%-261.00
iShares Micro-Cap ETF3.44K0.13%-
Fidelity Nasdaq Composite Index2.52K0.10%-
NT Quality SCC US Fund - L2.23K0.09%-178.00
NT Quality Small Cap Core2.23K0.09%-178.00

Recent Insider Transactions

DateNameRoleActivityValue
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$22.53K
Nov 15, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$30.01K
Nov 18, 2024SEKHRI PAUL J Pres, CEO and Exec ChairpersonBuy$31.27K
Nov 29, 2022FRY JOHN A-Buy$33.77K
Nov 28, 2022FRY JOHN A-Buy$16.97K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q43-
2024 Q2--

VTVT Ownership FAQ

Who Owns vTv Therapeutics?

vTv Therapeutics shareholders are primarily institutional investors at 8.91%, followed by 35.60% insiders and 55.49% retail investors. The average institutional ownership in vTv Therapeutics's industry, Biotech Stocks , is 306.59%, which vTv Therapeutics falls below.

Who owns the most shares of vTv Therapeutics?

vTv Therapeutics’s largest shareholders are Samsara biocapital (206.78K shares, 3.14%), Baker bros. advisors lp (97.31K shares, 1.48%), and Connective capital management (9.71K shares, 0.15%). Together, they hold 4.76% of vTv Therapeutics’s total shares outstanding.

Does Blackrock own vTv Therapeutics?

BlackRock is not among the top 10 institutional shareholders of vTv Therapeutics.

Who is vTv Therapeutics’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is vTv Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.63% of its assets in 206.78K vTv Therapeutics shares, valued at 3.1M$.

Who is the top mutual fund holder of vTv Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of vTv Therapeutics shares, with 6.81% of its total shares outstanding invested in 178.2K vTv Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools